COPENHAGEN, Aug 18 (Reuters) - Novo Nordisk A/S said on Monday it had accepted a near $90,000 fine from Danish regulators for failing to inform investors quickly enough that a drug it had hoped would become its next growth driver had been refused U.S. approval.
cancer in former smokers prompted diabetes experts such as Novo Nordisk and Eli Lilly to discontinue their inhaled insulin products ..... insulin class with a negative stigma. Diabetes giants such as Novo and Lilly have pulled their inhaled insulins from development
next two months are going to be very interesting for Novo Nordisk (NYSE: NVO ) - a large cap pharma company with a strong position in the insulin segment. Novo Nordisk is one of those companies that just keeps doing incredibly
Novo Nordisk A/S (NYSE: NVO ) Q2 2014 Earnings Call ..... Executive Vice President Jesper Brandgaard - Chief Financial Officer ..... Chairman of the Board - Novo Nordisk Engineering A/S and Chairman of the Board - Novo Nordisk IT A/S Presentation
Novo Nordisk ( NVO -2.2% ) Q2 results ((DKK M)): 21,629 (+6.3%); Gross Profit: 17,958 (+6.4%); Operating Income: 8
The following audio is from a conference call that will begin on August 07, 2014 at 07:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now Complete Story »
Novo Nordisk reported second-quarter results that were ..... s launch in the United States. We think Novo 's strong portfolio of diabetes therapies ..... innovation give the firm a stable, wide moat. Novo 's top line grew by 1% to DKK 21.6 billion
Novo Nordisk (NYSE: NVO ): Q2 EPS of DKK2.66 beats by DKK0.06 . Revenue of DKK21.63B (+1.2% Y/Y) Press Release Post your comment!
* Shares up 1.5 pct (Adds comments from CEO, analysts, share price)
COPENHAGEN, Aug 7 (Reuters) - Novo Nordisk could receive an approval from the U.S. Food and Drug Administration for Tresiba by the end of next year, paving the way for its launch in the United States at the start of 2016, the company's chief executive said on Thursday.